These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26593700)

  • 1. The Molecular Basis for Dual Fatty Acid Amide Hydrolase (FAAH)/Cyclooxygenase (COX) Inhibition.
    Palermo G; Favia AD; Convertino M; De Vivo M
    ChemMedChem; 2016 Jun; 11(12):1252-8. PubMed ID: 26593700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual cyclooxygenase-fatty acid amide hydrolase inhibitor exploits novel binding interactions in the cyclooxygenase active site.
    Goodman MC; Xu S; Rouzer CA; Banerjee S; Ghebreselasie K; Migliore M; Piomelli D; Marnett LJ
    J Biol Chem; 2018 Mar; 293(9):3028-3038. PubMed ID: 29326169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti-inflammatory drug-dependent gastrointestinal damage.
    Sasso O; Migliore M; Habrant D; Armirotti A; Albani C; Summa M; Moreno-Sanz G; Scarpelli R; Piomelli D
    FASEB J; 2015 Jun; 29(6):2616-27. PubMed ID: 25757568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies.
    Migliore M; Habrant D; Sasso O; Albani C; Bertozzi SM; Armirotti A; Piomelli D; Scarpelli R
    Eur J Med Chem; 2016 Feb; 109():216-37. PubMed ID: 26774927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Double Whammy: Targeting Both Fatty Acid Amide Hydrolase (FAAH) and Cyclooxygenase (COX) To Treat Pain and Inflammation.
    Scarpelli R; Sasso O; Piomelli D
    ChemMedChem; 2016 Jun; 11(12):1242-51. PubMed ID: 26486424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the fatty acid amide hydrolase and cyclooxygenase inhibitory properties of novel amide derivatives of ibuprofen.
    Deplano A; Karlsson J; Svensson M; Moraca F; Catalanotti B; Fowler CJ; Onnis V
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):815-823. PubMed ID: 32200655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of fatty acid amide hydrolase and cyclooxygenase by the N-(3-methylpyridin-2-yl)amide derivatives of flurbiprofen and naproxen.
    Cipriano M; Björklund E; Wilson AA; Congiu C; Onnis V; Fowler CJ
    Eur J Pharmacol; 2013 Nov; 720(1-3):383-90. PubMed ID: 24120370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer aided drug design approaches to develop cyclooxygenase based novel anti-inflammatory and anti-cancer drugs.
    Reddy RN; Mutyala R; Aparoy P; Reddanna P; Reddy MR
    Curr Pharm Des; 2007; 13(34):3505-17. PubMed ID: 18220787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of carprofen as a multitarget fatty acid amide hydrolase/cyclooxygenase inhibitor.
    Favia AD; Habrant D; Scarpelli R; Migliore M; Albani C; Bertozzi SM; Dionisi M; Tarozzo G; Piomelli D; Cavalli A; De Vivo M
    J Med Chem; 2012 Oct; 55(20):8807-26. PubMed ID: 23043222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of cyclooxygenase enzymes (COXs) selective inhibition.
    Limongelli V; Bonomi M; Marinelli L; Gervasio FL; Cavalli A; Novellino E; Parrinello M
    Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5411-6. PubMed ID: 20215464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of the N-(3-Methylpyridin-2-yl)amide Derivatives of Flurbiprofen and Ibuprofen with FAAH: Enantiomeric Selectivity and Binding Mode.
    Karlsson J; Morgillo CM; Deplano A; Smaldone G; Pedone E; Luque FJ; Svensson M; Novellino E; Congiu C; Onnis V; Catalanotti B; Fowler CJ
    PLoS One; 2015; 10(11):e0142711. PubMed ID: 26565710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor.
    Gouveia-Figueira S; Karlsson J; Deplano A; Hashemian S; Svensson M; Fredriksson Sundbom M; Congiu C; Onnis V; Fowler CJ
    PLoS One; 2015; 10(9):e0139212. PubMed ID: 26406890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and
    Deplano A; Karlsson J; Moraca F; Svensson M; Cristiano C; Morgillo CM; Fowler CJ; Russo R; Catalanotti B; Onnis V
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):940-953. PubMed ID: 33896320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxicams bind in a novel mode to the cyclooxygenase active site via a two-water-mediated H-bonding Network.
    Xu S; Hermanson DJ; Banerjee S; Ghebreselasie K; Clayton GM; Garavito RM; Marnett LJ
    J Biol Chem; 2014 Mar; 289(10):6799-6808. PubMed ID: 24425867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A binding site for nonsteroidal anti-inflammatory drugs in fatty acid amide hydrolase.
    Bertolacci L; Romeo E; Veronesi M; Magotti P; Albani C; Dionisi M; Lambruschini C; Scarpelli R; Cavalli A; De Vivo M; Piomelli D; Garau G
    J Am Chem Soc; 2013 Jan; 135(1):22-5. PubMed ID: 23240907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic insights into cyclooxygenase irreversible inactivation by aspirin.
    Tosco P; Lazzarato L
    ChemMedChem; 2009 Jun; 4(6):939-45. PubMed ID: 19301318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzimidazole scaffold based hybrid molecules for various inflammatory targets: Synthesis and evaluation.
    Kaur G; Silakari O
    Bioorg Chem; 2018 Oct; 80():24-35. PubMed ID: 29864685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fatty acid amide hydrolase and cyclooxygenase-inhibitory properties of novel amide derivatives of carprofen.
    Deplano A; Karlsson J; Fowler CJ; Onnis V
    Bioorg Chem; 2020 Aug; 101():104034. PubMed ID: 32599361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ruthenium(ii) arene NSAID complexes: inhibition of cyclooxygenase and antiproliferative activity against cancer cell lines.
    Mandal P; Kundu BK; Vyas K; Sabu V; Helen A; Dhankhar SS; Nagaraja CM; Bhattacherjee D; Bhabak KP; Mukhopadhyay S
    Dalton Trans; 2018 Jan; 47(2):517-527. PubMed ID: 29235601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoxazole-Based-Scaffold Inhibitors Targeting Cyclooxygenases (COXs).
    Perrone MG; Vitale P; Panella A; Ferorelli S; Contino M; Lavecchia A; Scilimati A
    ChemMedChem; 2016 Jun; 11(11):1172-87. PubMed ID: 27136372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.